A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Stirrett, Karen L ^a   Ferreras, Julian A ^a   Rossi, Sebastian M ^a,b   Moy, Richard L ^a   Fonseca, Fabio V ^a,c   Quadri, Luis E N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSIDAD NACIONAL DE MISIONES   (Argentina)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL RNA; SOLVENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CONTROL; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENOMIC FRAGMENT; NONHUMAN; YERSINIA PESTIS; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; CHROMOSOME MAP; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; IC 50; MICROBIOLOGICAL EXAMINATION; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI; YERSINIA PESTIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CHROMOSOME MAPPING; CHROMOSOMES, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOME, BACTERIAL; GENOMIC LIBRARY; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SOLVENTS; YERSINIA PESTIS;

EID: 49149091531     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-122     Document Type: Article

References (37)

1. Factors promoting acute and chronic diseases caused by yersiniae. RR Brubaker, Clin Microbiol Rev 1991 4 3 309 324 1889045
2. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. TV Inglesby DT Dennis DA Henderson JG Bartlett MS Ascher E Eitzen AD Fine AM Friedlander J Hauer JF Koerner M Layton J McDade MT Osterholm T O'Toole G Parker TM Perl PK Russell M Schoch-Spana K Tonat, JAMA 2000 283 17 2281 2290 10.1001/jama.283.17.2281 10807389
3. Medical management of biological casualties handbook. Fort Detrick, Frederick, MD, U.S. Army Medical Research Institute of Infectious Diseases, Eitzen E, Pavlin J, Cieslak T, Christopher G, Culpepper R, 3rd 1998
4. NIAID category A, B, and C priority pathogens (2007). NIAID, http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/research/CatA.htm
5. Yersinia pestis - etiologic agent of plague. RD Perry JD Fetherston, Clin Microbiol Rev 1997 10 1 35 66 8993858
6. Plague. MB Prentice L Rahalison, Lancet 2007 369 9568 1196 1207 10.1016/S0140-6736(07)60566-2 17416264
7. World Health Organization. Human plague in 2000 and 2001. Wkly Epidemiol Rec 2004 79 301 308 15369044
8. Emerging infectious disease: what are the relative roles of ecology and evolution? SJ Schrag P Wiener, Trends Ecol Evol 1995 10 319 324 10.1016/S0169-5347(00)89118-1
9. Treatment of plague. JD Poland DT Dennis, Plague manual: epidemiology, distribution, surveillance and control Geneva, World Health Organization 1999 55 62
10. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. RA Greenfield MS Bronze, Drug Discov Today 2003 8 19 881 888 10.1016/S1359-6446(03)02847-2 14554016
11. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. M Galimand A Guiyoule G Gerbaud B Rasoamanana S Chanteau E Carniel P Courvalin, N Engl J Med 1997 337 10 677 680 10.1056/NEJM199709043371004 9278464
12. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. JA Ferreras JS Ryu F Di Lello DS Tan LE Quadri, Nat Chem Biol 2005 1 1 29 32 10.1038/nchembio706 16407990
13. Exploiting ligand conformation in selective inhibition of non-ribosomal peptide synthetase amino acid adenylation with designed macrocyclic small molecules. JS Cisar JA Ferreras RK Soni LE Quadri DS Tan, J Am Chem Soc 2007 129 25 7752 7753 10.1021/ja0721521 17542590
14. Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis. KL Stirrett JA Ferreras V Jayaprakash BN Sinha T Ren LE Quadri, Bioorg Med Chem Lett 2008 18 2662 2668 10.1016/j.bmcl.2008.03.025 18394884
15. Strategic paradigm shifts in the antimicrobial drug discovery process of the 21st century. LEN Quadri, Infect Disord Drug Targets 2007 7 3 230 237 10.2174/187152607782110040 17897059
16. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. X Li M Zolli-Juran JD Cechetto DM Daigle GD Wright ED Brown, Chem Biol 2004 11 10 1423 1430 10.1016/j.chembiol.2004.08.014 15489169
17. Biochemical characterization of a novel hypoxanthine/xanthine dNTP pyrophosphatase from Methanococcus jannaschii. JH Chung JH Back YI Park YS Han, Nucleic Acids Res 2001 29 14 3099 3107 11452035 10.1093/nar/29.14.3099
18. Identification of an ITPase/XTPase in Escherichia coli by structural and biochemical analysis. J Zheng VK Singh Z Jia, Structure 2005 13 10 1511 1520 10.1016/j.str.2005.07.007 16216582
19. Transcriptional activation of promoters of the superoxide and multiple antibiotic resistance regulons by Rob, a binding protein of the Escherichia coli origin of chromosomal replication. KW Jair X Yu K Skarstad B Thony N Fujita A Ishihama RE Wolf Jr., J Bacteriol 1996 178 9 2507 2513 8626315
20. Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. RR Ariza Z Li N Ringstad B Demple, J Bacteriol 1995 177 7 1655 1661 7896685
21. Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli. H Nakajima K Kobayashi M Kobayashi H Asako R Aono, Appl Environ Microbiol 1995 61 6 2302 2307 7793951
22. A rob-like gene of Enterobacter cloacae affecting porin synthesis and susceptibility to multiple antibiotics. EH Lee E Collatz I Podglajen L Gutmann, Antimicrob Agents Chemother 1996 40 9 2029 2033 8878575
23. MarA-mediated transcriptional repression of the rob promoter. T Schneiders SB Levy, J Biol Chem 2006 281 15 10049 10055 10.1074/jbc.M512097200 16478729
24. Cloning of organic solvent tolerance gene ostA that determines n-hexane tolerance level in Escherichia coli. R Aono T Negishi H Nakajima, Appl Environ Microbiol 1994 60 12 4624 4626 7811102
25. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. DG White JD Goldman B Demple SB Levy, J Bacteriol 1997 179 19 6122 6126 9324261
26. RobA-induced multiple antibiotic resistance largely depends on the activation of the AcrAB efflux. T Tanaka T Horii K Shibayama K Sato S Ohsuka Y Arakawa K Yamaki K Takagi M Ohta, Microbiol Immunol 1997 41 9 697 702 9343820
27. Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities. IT Paulsen MK Sliwinski MH Saier Jr., J Mol Biol 1998 277 3 573 592 10.1006/jmbi.1998.1609 9533881
28. Analysis of a complete library of putative drug transporter genes in Escherichia coli. K Nishino A Yamaguchi, J Bacteriol 2001 183 20 5803 5812 11566977 10.1128/JB.183.20.5803-5812.2001
29. Structure and function of TolC: the bacterial exit duct for proteins and drugs. V Koronakis J Eswaran C Hughes, Annu Rev Biochem 2004 73 467 489 10.1146/annurev.biochem.73.011303.074104 15189150
30. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. LJ Piddock, Clin Microbiol Rev 2006 19 2 382 402 16614254 10.1128/CMR.19.2.382-402.2006
31. Molecular cloning: a laboratory manual. J Sambrook DW Russell, Cold Spring Harbor, NY, Cold Spring Harbor Press 3rd 2001
32. Resistance to pesticin, storage of iron, and invasion of HeLa cells by Yersiniae. DJ Sikkema RR Brubaker, Infect Immun 1987 55 3 572 578 3818085
33. Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis. RD Perry ML Pendrak P Schuetze, J Bacteriol 1990 172 10 5929 5937 2211518
34. Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide. M Palma D DeLuca S Worgall LE Quadri, J Bacteriol 2004 186 1 248 252 14679246 10.1128/JB.186.1.248-252.2004
35. Transcriptome analysis of the Pseudomonas aeruginosa response to iron. M Palma S Worgall LE Quadri, Arch Microbiol 2003 180 5 374 379 10.1007/s00203-003-0602-z 14513207
36. Applied Biosystems. 1997. ABI PRISM 7700 Sequence Detection System, User Bulletin. 1997 2 1 36
37. Structural requirements for marbox function in transcriptional activation of mar/sox/rob regulon promoters in Escherichia coli: sequence, orientation and spatial relationship to the core promoter. RG Martin WK Gillette S Rhee JL Rosner, Mol Microbiol 1999 34 3 431 441 10.1046/j.1365-2958.1999.01599.x 10564485